Cantor Fitzgerald analyst Pablo Zuanic on Friday reiterated a neutral rating on Aurora Cannabis and cut his 12-month price target to C$7.60 from C$10.75 due to reduced sales estimates. The company said it expects to reach positive Ebitda by the first half of fiscal year 2023, but Zuanic said the company remains a long-term turnaround story. "We realize pressures in the domestic recreational unit, in part, offset progress in other areas, so trend-wise we are constructive, but do not have enough f Read More...
Cantor Fitzgerald analyst Pablo Zuanic on Friday reiterated a neutral rating on Aurora Cannabis and cut his 12-month price target to C$7.60 from C$10.75 due to reduced sales estimates. The company said it expects to reach positive Ebitda by the first half of fiscal year 2023, but Zuanic said the company remains a long-term turnaround story. “We realize pressures in the domestic recreational unit, in part, offset progress in other areas, so trend-wise we are constructive, but do not have enough f
